
News and Announcements
Apr 28, 2023
Functional outcomes are equivalent after HoLEP regardless of receipt of prior BPH procedure
Nick Dean presented a study at the 2023 American Urological Association Annual Meeting, revealing that HoLEP's functional outcomes were comparable in patients, regardless of prior BPH procedures. This indicates that HoLEP remains effective in improving urinary symptoms and preserving bladder function, irrespective of a patient's BPH treatment history
Aug 28, 2022
Dr. Amy Krambeck discusses study comparing lithotripters for stone removal
Amy E. Krambeck, MD, discusses her recent trial1comparing the efficacy of Trilogy and ShockPulse-SE lithotripters used in percutaneous nephrolithotomy (PCNL). Krambeck et al found that both devices are highly efficient and serve as notable advancements in stone-removal technologies, although fewer device malfunctions were reported when the Trilogy device was utilized.
Apr 1, 2022
HOLEP: A SIZE-INDEPENDENT, DEFINITIVE THERAPY FOR BPH
Amy E. Krambeck, MD, chief of the Division of Endourology and Stone Disease, and professor of Urology at Northwestern Medicine, is a world leader in holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH). In this video, Dr. Krambeck discusses the benefits of and surgical indications for HoLEP, and the impacts of upgraded MOSES laser technology.
Feb 6, 2022
Advances in Treatment for Benign Prostate Hypertrophy (BPH)
Dr. Amy Krambeck, MD, a urologist at Northwestern Memorial Hospital and professor of urology at Northwestern University Feinberg School of Medicine discusses benign prostate hypertrophy (BPH) and the latest advancement in treatment options such as the new way to perform the HoLEP (Holmium Laser Enucleation of Prostate) procedure that is narcotics-free and allows 85% of patients to go home the same day.
Jan 21, 2022
Medical Moment: One and done treatment for BPH
In an interview with 16 News Now, Amy Krambeck, MD discusses the benefits of holmium laser enucleation of the prostate with an upgraded MOSES laser as a surgical treatment for lower urinary tract symptoms related to benign prostatic hyperplasia (BPH).
Jan 5, 2022
Patient removal of ureteral stent with extraction string is safe and economical
In an interview with Urology Times, Amy E. Krambeck, MD, discusses findings on the recent Urology Practice study, “The Economic Burden of Cystoscopy-Based Ureteral Stent Removal in the United States: An Analysis of Nearly 30,000 Patients.” She concluded that extraction strings may offer a safe and cost effective method for stent removals.
Apr 4, 2021
Lithotripters Trilogy and ShockPulse-SE show efficacy for stones
In a recent trial comparing the efficacy of Trilogy and ShockPulse-SE lithotripters used in percutaneous nephrolithotomy (PCNL), investigators found that both devices are highly efficient and serve as notable advancements in stone-removal technologies, although fewer device malfunctions were reported when the Trilogy device was utilized. “For harder, more aggressive stones, I'm more likely to use the Trilogy based on the results of the study. If I have a softer, easier stone, I prefer the lightness of the ShockPulse," said lead study investigator Amy E. Krambeck, MD.
May 18, 2020
MOSES-enabled pulsed laser allows same-day discharge without catheter
The benefits of holmium laser enucleation of the prostate with MOSES-enabled pulsed laser modulation justify its consideration as the gold standard surgical treatment for lower urinary tract symptoms related to benign prostatic hyperplasia, according to Amy E. Krambeck, MD.